Time To Build Without VCs
In victory over polio, hope for the battle against COVID-19
Stocks Amid COVID-19 Outbreak: Winners So Far in the Health Industry
George Soros: the coronavirus endangers our civilization
Covid-19 roundup: Gilead selects 5 generic manufacturing partners for remdesivir; CanSino outlines PhI/II study in Canada
Macro Briefing | 13 May 2020
Pfizer Plans To Test Covid-19 Vaccine On Thousands Of Patients By September- Report
Gilead Signs Remdesivir Licensing Agreements With Five Drugmakers
Merck CPO Julie Gerberding On The Deadliness Of Covid-19
CEO Albert Bourla On Pfizer’s Involvement With Covid-19
Epic CEO Judy Faulkner on developing new therapies for COVID-19
Moderna CEO Stephane Bancel & Regeneron CEO Leonard Schleifer on a Coronavirus vaccine
Bristol Myers Squibb CEO Giovanni Caforio On COVID-19 Vaccines
Why MyoKardia (MYOK) Stock Could Rise Another 30%
Moderna’s Covid-19 Vaccine Candidate Gets FDA Fast Track Status
Emerging from the Great Lockdown in Asia and Europe
Ex-DARPA chief Regina Dugan, Illumina founder Jay Flatley join Wellcome Trust fund to tackle global health's Sputnik moment
The Safest Dividend Stocks to Hold Today
Genfit Craters 49% On Failed NASH Trial; Top Analyst ‘Not Surprised’
Novavax Spikes 31% on $384 Million Cash Injection for Vaccine Production
Inovio’s COVID-19 Vaccine Candidate Has the Edge Over Moderna’s, Says 5-Star Analyst
Why Warren Buffett Is More Concerned About Pandemics Than Wars And Financial Crises
Coronavirus recovery would be quickest or slowest in these cities
Solid Biosciences: Keep Your Eyes On The Prize Says Top Analyst
Seres Therapeutics Reports Weak Earnings, But Significant Upside Lies Ahead
Weekly Market Review: Stocks Back to Winning Ways
Apple to Reopen Some U.S. Stores Next Week
Quidel’s Rapid Covid-19 Antigen Test Scores Emergency FDA Approval
Pfizer Sets Wheels In Motion For Covid-19 Vaccine Production Ramp
Gilead’s Remdesivir Will Be Distributed By State Health Departments